Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) EBIT (2016 - 2025)

Historic EBIT for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $78.7 million.

  • Healthequity's EBIT rose 30099.36% to $78.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $293.5 million, marking a year-over-year increase of 8453.08%. This contributed to the annual value of $162.3 million for FY2025, which is 3792.3% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's EBIT is $78.7 million, which was up 30099.36% from $89.6 million recorded in Q3 2025.
  • Over the past 5 years, Healthequity's EBIT peaked at $89.6 million during Q3 2025, and registered a low of -$27.2 million during Q1 2022.
  • Its 5-year average for EBIT is $25.7 million, with a median of $21.4 million in 2023.
  • The largest annual percentage gain for Healthequity's EBIT in the last 5 years was 161420.77% (2022), contrasted with its biggest fall of 161707.62% (2022).
  • Over the past 5 years, Healthequity's EBIT (Quarter) stood at -$366000.0 in 2021, then soared by 1614.21% to $5.5 million in 2022, then surged by 457.4% to $30.9 million in 2023, then plummeted by 36.47% to $19.6 million in 2024, then skyrocketed by 300.99% to $78.7 million in 2025.
  • Its last three reported values are $78.7 million in Q4 2025, $89.6 million for Q3 2025, and $83.1 million during Q2 2025.